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Abstract Coronary calcium scoring (CCS) adds to the
diagnostic performance of myocardial perfusion single-
photon emission computed tomography (SPECT) to assess
the presence of significant coronary artery disease (CAD).
Patients with a high pre-test likelihood are expected to have
a high CCS which potentially could enhance the diagnostic
performance of myocardial perfusion SPECT in this spe-
cific patient group. We evaluated the added value of CCS
to SPECT in the diagnosis of significant CAD in patients
with an intermediate to high pre-test likelihood. In total,
129 patients (mean age 62.7 ± 9.7 years, 65 % male) with
stable anginal complaints and intermediate to high pre-test
likelihood of CAD (median 87 %, range 22–95) were
prospectively included in this study. All patients received
SPECT and CCS imaging preceding invasive coronary
angiography (CA). Fractional flow reserve (FFR) mea-
surements were acquired from patients with angiographi-
cally estimated 50–95 % obstructive CAD. For SPECT a
SSS [ 3 was defined significant CAD. For CCS the opti-
mal cut-off value for significant CAD was determined by
ROC curve analysis. The reference standard for significant
CAD was a FFR of \0.80 acquired by CA. Significant
CAD was demonstrated in 64 patients (49.6 %). Optimal
CCS cut-off value for significant CAD was [182.5. ROC
curve analysis for prediction of the presence of significant
CAD for SPECT, CCS and the combination of CCS and
SPECT resulted in an area under the curve (AUC) of 0.88
(95 % CI 81–94), 0.75 (95 % CI 66–83 %) and 0.92 (95 %
CI 87–97 %) respectively. The difference of the AUC
between SPECT and the combination of CCS and SPECT
was 0.05 (P = 0.12). The addition of CCS did not signif-
icantly improve the diagnostic performance of SPECT in
the evaluation of patients with a predominantly high pre-
test likelihood of CAD.
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Introduction
According to current guidelines invasive coronary angi-
ography (CA) is a suitable diagnostic procedure for
patients with a high pre-test likelihood of significant cor-
onary artery disease either with or without troublesome
symptoms or clinical findings [1, 2]. In this population the
reported diagnostic yield of invasive CA is 44–88 % [3–5].
In real life invasive CA has an even lower diagnostic yield
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of obstructive CAD of about 38 % [6]. Non-invasive test-
ing could be of value to defer from invasive diagnostic
procedures, even in a subset of patients with an interme-
diate to high pre-test likelihood of CAD.
Nuclear myocardial perfusion imaging (MPI) with sin-
gle-photon emission computed tomography (SPECT) is
known for its role in diagnosis, risk stratification and
guidance of treatment decision making in the general
population [7, 8]. However, diagnostic performance in
patients with a high pre-test likelihood of CAD is low with
a sensitivity of 56–94 % [3, 9]. Additional anatomical
information could be of value to increase diagnostic per-
formance in this subset of patients.
Coronary calcium scoring (CCS) is known for its role in
risk prediction for a-symptomatic patients. Patients with
CCS \10 are at low risk of major cardiovascular events
during follow-up [10, 11]. In symptomatic patients the
value of CCS is disputed. Although the prevalence of
significant disease is low and the follow-up is favorable in
patients with a CCS\10, the prevalence of[50 % stenosis
in this category might still be 12–65 % [12–16]. Functional
imaging could be of added value to identify these patients.
With the advent of integrated SPECT and Computed
Tomography (CT) systems and the use of low dose CCS
scans for attenuation correction purposes, high quality
anatomical and functional data are readily available
[17, 18]. SPECT findings suggestive of myocardial ische-
mia are associated with high CCS, vice versa it was sug-
gested that low CCS associated with these findings could
obviate the need for further invasive testing [19, 20]. On
the other hand in patients with normal SPECT findings a
high CCS could be suggestive of significant CAD [21–23].
We evaluated the influence of the pre-test likelihood of
significant CAD on these findings and hypothesized that in
a subset of patients with an intermediate to high pre-test
likelihood of CAD there would be added value of CCS to
the diagnostic performance of SPECT.
Materials and methods
Study population
Patients with an intermediate to high pre-test likelihood of
CAD were prospectively enrolled in this study. Pre-test
likelihood was calculated according to Diamond and For-
rester criteria [24]. Intermediate pre-test likelihood was
defined as 13–87 % and high pre-test likelihood was
defined as [87 %, similar to boundaries used in literature
[2]. Excluded were patients with a known history of CAD
defined as any unstable coronary condition, myocardial
infarction, coronary revascularization or diagnostic Q wave
on baseline ECG. Also patients with a known history of
non-ischemic cardiomyopathy or a cardiac rhythm other
than sinus rhythm were excluded. By non-invasive assess-
ment, CAD was defined as a summed stress score (SSS) of
[3 on SPECT or the presence of significant coronary cal-
cification defined by a CSS cut-off value of[0 or the cut-off
value defined by receiver operating characteristics (ROC)
curve analysis. Fractional flow reserve measurements served
as the standard of reference, an FFR\0.80 was used for de
definition of hemodynamically significant CAD. The study
conformed to the principles outlined in the declaration of
Helsinki and was approved by the local ethics committee.
Written informed consent was obtained from all patients.
Image acquisition
All patients received SPECT and CCS imaging followed
by CA, including those patients with normal SPECT and
CCS results as part of the prospective study. Gated SPECT
and CCS images were acquired from a Hybrid SPECT-CT
system, CardioMD gamma camera and Brilliance 64-slice
CT scanner (Philips Medical Systems, Best, The Nether-
lands) with a 2-day stress/rest MPI protocol. Stress images
were considered normal if no perfusion defect was visu-
alized, SSS was\3, no wall motion abnormalities (WMA)
or [10 % transient ischemic dilatation (TID) were present
and left ventricular ejection fraction (LVEF) was [50 %
(male and female). Patients with abnormal stress SPECT
findings underwent rest imaging and CA at the second day
of imaging. Patients with normal stress SPECT findings
only underwent CA at the second day. The second imaging
day was scheduled within 14 days of the first. CCS was
performed in the stress SPECT imaging session.
Bicycle stress according to a stepwise protocol or
pharmacological stress (adenosine at standard rate of
0.14 mg/kg/min over 6 min) was performed for stress
image acquisition. In case the target heart rate was not
reached at maximum exercise stress, atropine was given at
the discretion of the attending physician. For stress and rest
SPECT a weight adjusted dose of 400–600 MBq of 99mTc-
sestamibi was used. Attenuation correction was performed
for all images using the CT non-enhanced calcium scan.
SPECT data were analyzed by two experienced nuclear
medicine physicians with regard to the presence of
reversible and/or fixed perfusion defects on short axis and
vertical and horizontal long axis slices. Semiquantitive
perfusion data and gated data with respect to WMA, TID
and LVEF were included in the analysis using the QGS/
QPS software package (Cedars-Sinai Medical Center, Los
Angeles, Ca, USA).
A nonenhanced scan to calculate the total CCS was
performed with the following scanning parameters: pro-
spective ECG triggering, at inspiration, 2.5 mm slice
thickness, 120 kV tube voltage, 55 mAs tube current.
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Agatston scores were computed using the Extended Bril-
liance Workspace software (Philips Medical Systems, Best,
The Netherlands).
As part of the prospective study, CA was performed in
all patients, including those with normal non-invasive test
results. CA was acquired on Allura (Philips Medical
Systems, Best, The Netherlands) catheterization equipment
via femoral or radial artery access. From all patients
biplane views were acquired from all major coronary
arteries. Additional views were obtained at the discretion
of the performing operator. FFR measurements were
obtained from patients with angiographically estimated
50–95 % obstructive disease. During FFR measurement
distal coronary pressure was measured with a pressure
guidewire (Certus Wire, Radi Medical Systems, Uppsala,
Sweden) during maximal hyperemia induced by adenosine
intravenously at 0.14 mg/kg/min, with simultaneous mea-
surement of aortic pressure through the catheter. FFR was
calculated as the ratio between mean distal pressure and
mean aortic pressure [25]. The angiograms were visually
evaluated for lesion severity according to 5 categories of
luminal loss: no CAD (0 % luminal loss), mild lesion
severity (luminal loss 0–50 %), intermediate lesion
severity (luminal loss 50–70 %), severe lesions (luminal
loss 70–99 %) and total occlusion. Interpretation was
performed on a consensus basis by two experienced car-
diologists. Occluded vessels were considered severely
stenotic with an FFR of 0.50. Vessels with angiographi-
cally [95 % obstructive disease were considered severely
stenotic with an FFR \0.80. Normal vessels (\10 %
luminal loss) were considered not severely stenotic; FFR
[0.80. As a result, FFR measurements were available
from 47 of the patients with angiographically estimated
50–95 % obstructive disease (84 %). Significant disease
was defined as an FFR \0.80.
All imaging modalities were interpreted blinded for
clinical data and the respective other modalities.
Statistical analysis
Statistical analyses were performed with SPSS software
(version 18.0, IBM Corporation, Somers, New York,
USA). Continuous variables were expressed as mean ±
standard deviation (SD) or median and range (if distribu-
tion was skewed), and categorical variables as numbers and
percentages. Sensitivity, specificity, negative predictive
value (NPV) and positive predictive value (PPV) with
corresponding 95 % confidence intervals (CI) were calcu-
lated. ROC curve analysis was performed to calculate the
optimal cutoff value for the detection of significant CAD
by CCS. As a measure of discrimination we calculated the
area under the ROC curve (AUC) with 95 % confidence
intervals for CCS and SPECT for the detection of
significant CAD. Also binary logistic regression analysis
was used to construct the formula for the combination of
SPECT and CCS in the evaluation of the presence of sig-
nificant CAD. A P value of \0.05 was considered statis-
tically significant.
Results
Study population
In total, 129 patients (mean age 62.7 ± 9.7 years, 65 %
male) with stable anginal complaints and a predominantly
high pre-test likelihood of CAD (median pre-test proba-
bility 87 % (range 22–95)), were included in the study.
Sixty-nine patients (53.5 %) had more than three cardio-
vascular risk factors. Complete characteristics of the study
population are presented in Table 1.
Coronary angiography
CA showed significant CAD in 64 patients (49.6 %). The
distribution of vessel involvement is presented in Table 2.
From the 64 patients with significant CAD, 28 (43.8 %)
patients underwent CABG, 26 (40.6 %) patients underwent
percutaneous coronary intervention (PCI) and 10 (15.6 %)
patients were treated conservatively because of peripheral
or very diffuse disease. From the 66 patients without sig-
nificant CAD, 1 patient (1.5 %) underwent PCI, the
remainder was treated conservatively.
Myocardial perfusion SPECT
Exercise stress prior to image acquisition was performed in
103 patients (79.8 %), the remainder 26 (20.2 %) patients
underwent adenosine stress. 33 (32.0 %) patients required
atropine infusion to reach the target heart rate during
exercise stress. Mean LVEF after stress was 61.5 ± 9.0 %,
and at rest 64.9 ± 10.1 %. Mean transient ischemic dila-
tation was 8.2 ± 16.5 ml (median 6.0 ml, range -35 to
55). During stress testing, 32 (31.1 %) patients showed
ECG changes suggestive of myocardial ischemia (at least
2 mm ST-segment depression), 52 (50.5 %) patients had a
negative stress test and 19 (18.4 %) had either uninter-
pretable or equivocal stress ECG results. During adenosine
stress 3 (11.5 %) patients had positive ECG findings. From
the 57 patients with a SSS [3, 51 had significant CAD.
From the 13 patients with a false negative SPECT eight had
a pre-test likelihood ranging between 52 and 86 %. The
remaining five patients had a high pre-test likelihood,
[90 %. Data regarding the SPECT characteristics are
presented in Table 2. Diagnostic performance of SPECT is
presented in Table 3 and Fig. 1.
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Coronary calcium scoring
The median CCS of the study population was 145 (range
0–4142). For patients with significant CAD the median
CCS was 363 (range 0–4142), for patients without signif-
icant CAD the median CCS was 28 (range 0–2891,
P value \ 0.001). From the 97 patients with a CCS[0, 56
(58 %) had significant CAD. From the 32 patients with a
CCS of 0, eight (25 %) patients had significant CAD.
These patients had a pre-test likelihood of disease ranging
from 73 to 93 %. The distribution of CCS is presented in
Table 2. ROC curve analysis for the detection of significant
CAD using CCS in high pre-test likelihood patients gave
an optimal cutoff value of 182.5 for significant CAD,
yielding an area under the curve (AUC) of 0.75(95 % CI
0.66–0.83). (Figure 1) The sensitivity, specificity, NPV,
PPV and accuracy values of CCS are presented in Table 3.
Combined SPECT and CCS
Using a CCS cutoff value of [0 added to a SSS [3 on
SPECT led to the diagnosis of significant CAD in 104
patients, 61 (58.6 %) of these had significant CAD
according to the reference standard. Despite a CCS of 0
and a SSS\3 on SPECT, 3 patients of a total of 22 (12 %)
had significant CAD. By introducing the CCS cutoff value
of 182.5 added to a SSS[3 on SPECT, the number of false
positive results decreased without adding to the number of
false negatives (Table 3).
CCS added to the diagnostic accuracy of SPECT in 10
patients. Eight patients with a normal SPECT had a CCS
[1000. Two patients with a negative SPECT had a CCS of
respectively 245 and 369; they had an intermediate pre-test
likelihood of CAD. SPECT added to the diagnostic accu-
racy of CCS in 5 patients. Three patients with significant
CAD and a CCS of 0 and a negative SPECT had an
intermediate pre-test likelihood of CAD (Table 4).
ROC curve analysis for CCS, SPECT and the combi-
nation of SPECT and CCS resulted in an AUC of 0.75, 0.88
and 0.92 respectively. Both SPECT and the combination of
SPECT and CCS performed significantly better in the
evaluation of the presence of significant CAD than CCS,
P = 0.0093 and P \ 0.0001 respectively. However the
combination of SPECT and CCS performed comparable to
standalone SPECT, difference in AUC 0.05, P = 0.12
(Fig. 1).
Discussion
Our study shows no significant added value of CCS on top
of SPECT in a population with a predominantly high pre-
test likelihood of CAD. SPECT alone has a reasonable
performance with an NPV of 82 % and an AUC of 0.88 as
determined by ROC curve analysis. By adding CCS
information the NPV increased to 94 %, but at the cost of a
substantial number of false positives. As such the increased
AUC of 0.92 did not differ significantly from SPECT as
standalone procedure. Moreover, it failed to identify three
patients with significant CAD, a CCS of 0 and a negative
SPECT result.
In the overall patient population with anginal complaints
SPECT has a good diagnostic performance. Well-designed
studies have shown sensitivities ranging from 85 to 90 %.
If ECG gated information and attenuation correction
Table 1 Characteristics of the patients included in the analysis
Age (years)a 62.7 ± 9.7
Men 84 65.1 %
Women 45 34.9 %
Cardiac History
Paroxysmal atrial fibrillation 6 4.7 %
Pacemaker implantation 1 0.8 %
Risk factors
Smoking
Current 29 22.5 %
History 24 18.6 %
Hypertension 84 65.1 %
Diabetes mellitus 16 12.4 %
Dyslipidaemia 70 68.0 %
Family history 79 61.2 %
Risk factors C 3 69 53.5 %
Angina pectoris
Non-anginal 1 0.8 %
Atypical 40 31.0 %
Typical 88 68.2 %
CCS Angina class
Class I 8 6.2 %
Class II 111 86.0 %
Class III 10 7.8 %
Class IV 0 0.0 %
Systolic blood pressure (mmHg)a 135 ± 21
Diastolic blood pressure (mmHg)a 78 ± 15
Body mass index (kg/m2)a 27.0 ± 4.0
Cockroft creatinin clearance (ml/min)a 93.4 ± 26.5
Pre-test likelihoodb 0.87 (0.22–0.95)
Low 0 0.0 %
Intermediate 56 43.4 %
High 65 50.4 %
Unknown 8 6.2 %
Values are shown as number and percentage unless otherwise noted
CCS Canadian cardiovascular society
a Values expressed as mean ± standard deviation
b Values expressed as median (range)
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algorithms are used specificity values range between 80
and 90 % [7, 8]. In 123 patients with a high pre-test like-
lihood of disease Groutars et al. demonstrated a sensitivity
of 97 % and a specificity of 59 % for the detection of
[70 % lesions on CA [3]. More recently, Hamirani et al.
demonstrated a lower diagnostic performance of SPECT in
a high pre-test likelihood population of 122 patients with
sensitivity and specificity values of 58 and 43 %, respec-
tively [9]. Both groups used a 1 day dual isotope imaging
protocol with 201Tl rest imaging and 99mTc stress imaging.
The former population was truly high risk with a mean
pre-test likelihood of 92 ± 20 % and a prevalence of
[70 % stenosis in 80 % of the patients. The latter was
retrospectively constituted of patients who underwent
SPECT, CT coronary angiography and CA. The prevalence
of [70 % stenosis was 64 %, suggestive of a high risk
population. In our hands SPECT had a reasonable perfor-
mance with sensitivity and specificity values of 80 and
91 % respectively and an AUC of 0.88 for the detection of
significant CAD in a high pre-test likelihood population.
Coronary calcium scoring is known for risk prediction,
but it is unable to depict the coronary lumen and therefore
Table 2 Results of coronary
calcium scoring, myocardial
perfusion SPECT and invasive
coronary angiography
Values are shown as number
and percentage unless otherwise
noted
SPECT single photon emission
computed tomography, CAD
coronary artery disease
a Values expressed as
mean ± standard deviation
b A fractional flow reserve of
\0.80 was defined significant
CAD
Coronary calcium scoring
0 32 24.8 %
1–10 8 6.2 %
11–100 17 13.2 %
101–400 27 20.9 %
401–800 15 11.6 %
[800 30 23.3 %
Myocardial perfusion SPECT
Exercise stress 103 79.8 %
Adenosine stress 26 20.2 %
Summed stress score 0 53 41.1 %
Summed stress score 1–3 19 14.7 %
Summed stress score [ 3 57 44.2 %
Stress SPECT, n = 129
Left ventricle end diastolic volume, mla 107.1 ± 44.7
Left ventricle end systolic volume, mla 44.8 ± 30.8
Left ventricle ejection fraction, %a 61.5 ± 9.0
Rest SPECT, n = 87
Left ventricle end diastolic volume, mla 107.2 ± 46.3
Left ventricle end systolic volume, mla 41.4 ± 34.1
Left ventricle ejection fraction, %a 64.9 ± 10.1
Invasive coronary angiogram
Extent of significant CADb
No significant CAD 65 50.4 %
1-vessel disease 22 17.1 %
2-vessel disease 23 17.8 %
3-vessel disease or left main stenosis 19 14.7 %
Table 3 Diagnostic performance of SPECT, CCS and the combination of SPECT and CCS
Sensitivity Specificity PPV NPV TP/FP/TN/FN Accuracy
CCS [0 88 37 58 75 56/41/24/8 62
CCS [182.5 66 71 69 68 42/19/46/22 68
SSS [3 80 91 90 82 51/6/59/13 85
CCS [0 or SSS [3 95 34 59 88 61/43/22/3 64
CCS [182.5 or SSS [3 95 66 74 94 61/22/43/3 81
Diagnostic performance of single photon emission computed tomography (SPECT), coronary calcium scoring (CCS) or combinations for the
detection of significant coronary artery disease (CAD). A fractional flow reserve of \0.80 was defined significant CAD
PPP positive predictive value, NPV negative predictive value, TP true positive, FP false positive, TN true negative, FN false negative
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not suitable for the diagnosis or exclusion of flow limiting
CAD. In a population of patients referred for CA, the
incidence of significant CAD in patients with a CCS of
zero is 15–19 %. In a large symptomatic population
(N = 291) with a predominantly intermediate pre-test
likelihood of CAD, Gottlieb et al. found that among 72
patients with a CCS of zero, 15 % had a stenosis[70 % on
CA [12]. In our population 25 % of the patients with a CCS
of zero had significant CAD. This resulted in a sensitivity
of 88 % using a CCS greater than zero as a diagnostic tool
for significant CAD. Conversely the specificity was just
37 % using this cut-off value. The optimal CCS cut-off
value in our population for the detection of significant
CAD was 182.5 as calculated by ROC curve analysis. In
light of the inability of CCS to depict the coronary lumen,
let alone the functional consequences, this value remains
artificial. Which is demonstrated by an AUC of 0.75 as
determined by ROC curve analysis.
A false-negative SPECT in patients with balanced
ischemia is a well-known pitfall for clinicians. Several
authors have noted that a high CCS may have diagnostic
value in this patient category [17, 22]. Schepis et al.
showed that in patients with an intermediate risk of CAD a
CCS [709 is predictive for significant CAD ([50 %
stenosis) in patients with a normal SPECT. When CCS at
this cut-off value was added to SPECT, the sensitivity
increased from 76 to 86 % and specificity remained similar
(91 and 86 %, respectively) when compared to SPECT
alone [17]. In a selected population of 50 patients with a
normal SPECT and a CCS [1000, Ghadri et al. found a
74 % prevalence of stenosis[50 % [22]. Our data showed
that out of the 13 patients with a false-negative SPECT, 8
had a CCS [1000. And although median CCS in patients
without significant CAD was 29, still 5 % of patients with a
true negative SPECT had a CCS [1000. If we used CCS
[0 as a cut-off value for CAD we observed a NPV of 88 %
for the exclusion of significant CAD when added to
SPECT, although at the cost of a high number of false
positives, PPV 59 %. Adding the optimal CCS cut-off
value of 182.5 to SPECT, the number of false positive
results decreased. The PPV improved from 59 to 74 %, the
NPV of 88 % increased to 92 %. However, AUC as
determined by ROC curve analysis did not differ signifi-
cantly between the combination of CCS and SPECT and
standalone SPECT. This shows that in a group of patients
with high risk of CAD, excluding the presence of coronary
calcifications in patients with a normal SPECT makes the
exclusion of significant CAD reliable. However, a rela-
tively low or zero CCS does not completely rule out sig-
nificant CAD in these patients. One of the three patients
with a CCS of zero and a negative SPECT result had a
significant left main stenosis. When the presence of calci-
fications is proven in patients with a negative SPECT
result, however, the significance of CAD is not.
Several limitations of our study need to be taken into
account when interpreting the results. First, our study
population was at predominantly high-risk of CAD.
Patients with an intermediate to high pre-test likelihood
were allowed to be included and over 50 % of patients had
a high pre-test likelihood. Thus, this study is not exemplary
for the general clinical population referred for SPECT. The
majority of patients with false negative results had a high
pre-test likelihood of disease. Second, for each patient we
Fig. 1 ROC curve analysis for the detection of significant coronary
artery disease (CAD) by the use of coronary calcium scoring (CCS),
Single Photon Emission Tomography (SPECT) and the combination
of CCS and SPECT. A fractional flow reserve of \0.80 was defined
significant CAD. A CCS of 182.5 was optimal cutoff for the detection
of significant CAD. Area under the curve 0.75. The difference of the
AUC between SPECT and the combination of CCS and SPECT was
0.05 (P = 0.12)
Table 4 Distribution of coronary calcium scores and summed stress
scores for patients with significant coronary artery disease and either
CCS = 0 (N = 8) or SSS \ 3 (N = 13)
SPECT
SSS = 0
SPECT
SSS = 1–3
SPECT
SSS [ 3
CCS = 0 2 1 5
CCS = 1–10
CCS = 11–100
CCS = 101–400 1 1
CCS = 401–1000
CCS [ 1000 4 4
SPECT single photon emission computed tomography, CCS coronary
calcium score, SSS summed stress score
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chose the optimal stress protocol, either adenosine or
exercise. However, adenosine stress has a known limited
diagnostic performance compared to exercise stress. The
reason for not being able to reach an adequate heart rate
response during exercise, not only could be the reason to
switch to adenosine stress; this could also be the con-
founding factor for the increased presence of significant
CAD (f.i. peripheral atherosclerotic disease or chronic
obstructive pulmonary disease). As a result of the higher
prevalence of significant CAD, negative predictive value of
adenosine stress SPECT could be hampered. Despite the
fact that almost a quarter of the patients received adenosine
stress, the diagnostic performance of SPECT alone in this
population is reasonable. FFR measurements were avail-
able from 84 % of patients with angiographically 50–95 %
obstructive disease. According to available literature it is
safe to assume that lesions with \50 % stenosis have no
hemodynamic significance [26]. Nine patients with angio-
graphically 70–95 % obstructive disease did not receive
FFR measurements, mainly for practical reasons on a busy
catherization laboratory. The impact of the possible error
by the assumption that these lesions were indeed hemo-
dynamically significant is limited [26].
Conclusion
When using coronary calcification as additional informa-
tion to myocardial perfusion SPECT, physicians should be
aware that in a population with a predominantly high pre-
test likelihood of CAD, the presence of coronary calcifi-
cations does not reliably discriminate between the presence
and absence of significant CAD. Indeed a high CCS,[1000
in literature and [182,5 in our population, can identify
patients with significant CAD and a normal SPECT.
However, even in patients with significant CAD and a
normal SPECT result, the calcium score may be as low as
zero.
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